TY - JOUR T1 - Impurity D of Anticancer Drug Fulvestrant as a Potential Multifunctional Inhibitor for the Marburg Virus A1 - Haoqi Wang A1 - Nirmitee Mulgaonkar A1 - Samavath Mallawarachchi A1 - Sandun Fernando JF - Pharmacophore JO - Pharmacophore SN - 2229-5402 Y1 - 2021 VL - 12 IS - 3 DO - 10.51847/2hVQ1HunuP SP - 1 EP - 11 N2 - A commonality between viruses and cancer is their ability to seize cellular machinery to rapidly proliferate while suppressing the host’s innate immune response. Using probe molecules, specific sites within the virion protein 35 (VP35) of the Marburg virus that have a high affinity to dsRNA (also known as the interferon inhibitory domain, IID), RNA-dependent RNA polymerase (RdRp), and nucleoside triphosphates (NTPs) were identified in silico. Using the dsRNA- binding site as the target, three potential drug molecules FID, CBSMA, and DOCHE were screened. We discovered that FID has a unique ability to simultaneously bind to all the three key binding domains with high affinity – a property that none of the other screened drug-like candidates possessed. The ability of FID to bind onto multiple domains of VP35 is significant since this provides the potential to thwart a viral infection from several fronts simultaneously using a single drug to combat rapidly mutating viruses. UR - https://pharmacophorejournal.com/article/impurity-d-of-anticancer-drug-fulvestrant-as-a-potential-multifunctional-inhibitor-for-the-marburg-v-vhp9glohmvwqokp ER -